DTIL
PRECISION BIOSCIENCES INC · Healthcare · Market cap $206.7M
Insiders bought $2K net in the last 90 days ·1 seller, 3 buyers· 1 of 1 sale under Rule 10b5-1 plans· latest Form 4 filed Nov 12, 2026
Insider Buying
$63K
reported purchases (SEC code P)
Insider Selling
$459K
reported sales (SEC code S)
Unique Insiders
7
in the rolling window
Latest filing
Nov 12, 2026
Scimeca Dario
PRECISION BIOSCIENCES INC (DTIL) has 20 SEC Form 4 filings (36 transaction rows) in the rolling window, disclosed by 7 distinct insiders. Most recent filing: Nov 12, 2026.
Inside the rolling window, 7 insiders at PRECISION BIOSCIENCES INC reported 6 open-market purchases totaling $63K and 9 open-market sales totaling $459K. The most active filer is Chief Legal Officer Scimeca Dario with 3 filings. The most recent open-market filing is a sale of 2,821 shares by Chief Legal Officer Scimeca Dario, dated Nov 10, 2026, worth $28K.
- Industry:Biotechnology
- CEO:Michael Amoroso
- Employees:67
- HQ:Durham, NC, US
- IPO:2019-03-28
| Source | |||||||
|---|---|---|---|---|---|---|---|
Scimeca DarioFirst in 9 months | Chief Legal Officer | Sale | 2,821 | $28K | Nov 12 | -8.0% | SEC ↗ |
Frankel StanleyFirst in 10 months | Director | Purchase | 1,000 | $6K | Sep 30 | +18.2% | SEC ↗ |
Brown MelindaFirst in 10 months | Director | Purchase | 1,135 | $7K | Sep 29 | +19.7% | SEC ↗ |
Germano Geno JFirst in 7 months | Director | Purchase | 2,609 | $16K | Sep 29 | +19.7% | SEC ↗ |
| Chief Research Officer | Sale | 4,925 | $19K | Feb 19 | +88.8% | SEC ↗ | |
| President and CEO | Sale | 20,559 | $79K | Feb 19 | +88.8% | SEC ↗ | |
| Chief Financial Officer | Sale | 8,149 | $31K | Feb 19 | +88.8% | SEC ↗ | |
| General Counsel and Secretary | Sale | 4,925 | $19K | Feb 19 | +88.8% | SEC ↗ | |
Kelly John AlexanderFirst filing | Chief Financial Officer | Sale | 15,213 | $61K | Jan 22 | +74.1% | SEC ↗ |
Scimeca DarioFirst filing | General Counsel and Secretary | Sale | 8,854 | $36K | Jan 22 | +74.1% | SEC ↗ |
SMITH J. JEFFERSONFirst filing | Chief Research Officer | Sale | 10,200 | $41K | Jan 22 | — | SEC ↗ |
Amoroso MichaelFirst filing | President and CEO | Sale | 34,799 | $145K | Jan 22 | — | SEC ↗ |
Germano Geno JFirst filing | Director | Purchase | 3,000 | $14K | Dec 17 | — | SEC ↗ |
Brown MelindaFirst filing | Director | Purchase | 1,381 | $7K | Dec 17 | — | SEC ↗ |
Frankel StanleyFirst filing | Director | Purchase | 2,700 | $13K | Dec 17 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does DTIL have?
PRECISION BIOSCIENCES INC (DTIL) has 20 SEC Form 4 filings (36 transaction rows) in the rolling 365-day window, disclosed by 7 distinct insiders. Most recent filing: Nov 12, 2026.
When was the most recent SEC Form 4 filing for DTIL?
The most recent Form 4 filing for DTIL on Tracefour is dated Nov 12, 2026.
Who is the most active insider at DTIL?
The most active SEC Form 4 filer at DTIL in the rolling window is Chief Legal Officer Scimeca Dario, with 3 filings.
What is the net insider flow at DTIL over the last 6 months?
Over the trailing 180 days, insiders at DTIL have net bought $2K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at DTIL in the current window?
Inside the rolling window, insiders at DTIL bought $63K and sold $459K based on SEC Form 4 filings.
Can I get alerts for DTIL insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at PRECISION BIOSCIENCES INC (DTIL). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
PRECISION BIOSCIENCES INC is in the Healthcare sector.